A report on the sponsors of cancer treatment clinical trials and their approval and monitoring mechanisms /

Saved in:

Bibliographic Details
Author / Creator:	Gelband, Hellen.
Imprint:	Washington D.C. : National Research Council, 1999.
Description:	1 online resource
Language:	English
Subject:	Cancer -- Treatment. Oncology -- Research. Clinical trials. Neoplasms -- therapy. Clinical Trials as Topic -- standards. Cancer -- Treatment. Clinical trials. Oncology -- Research. United States. Electronic books.
Format:	E-Resource Book
URL for this record:	http://pi.lib.uchicago.edu/1001/cat/bib/11114568

Hidden Bibliographic Details
Other authors / contributors:	National Cancer Policy Board (U.S.)
ISBN:	0309583012 9780309583015
Notes:	Title from caption (viewed June 14, 2001). "February 1999." Includes bibliographical references.
Summary:	This report for the National Cancer Policy Board (NCPB) describes the procedures currently in place in the United States for approving and monitoring clinical trials of cancer treatments. Virtually all cancer clinical trials are funded by agencies of the federal government or the pharmaceutical industry, so the focus is on the requirements for each of these groups. The paper is intended as a jumping off point for the NCPB to consider some of the pressing policy issues surrounding clinical trials in cancer, though as yet, no specific follow-on projects have been initiated.

Similar Items